TY - JOUR
T1 - Pathogenic Mutation of TDP-43 Impairs RNA Processing in a Cell Type-Specific Manner
T2 - Implications for the Pathogenesis of ALS/FTLD
AU - Imaizumi, Kent
AU - Ideno, Hirosato
AU - Sato, Tsukika
AU - Morimoto, Satoru
AU - Okano, Hideyuki
N1 - Funding Information:
This work was supported by funding from Takeda Pharmaceutical Company, Ltd, Japan; Japan Agency for Medical Research and Development (AMED) Grants 19bm0804003, 20bm0804003, and 21bm0804003; and Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research 20H00485 (to H.O.) and Grant-in-Aid for Scientific Research on Innovative Areas “Singularity Biology (No. 8007)” Grant 21H00438 (to K.I.).
Publisher Copyright:
© 2022, Society for Neuroscience. All rights reserved.
PY - 2022/5/1
Y1 - 2022/5/1
N2 - Transactivating response element DNA-binding protein of 43 kDa (TDP-43), which is encoded by the TARDBP gene, is an RNA-binding protein with fundamental RNA processing activities, and its loss-of-function (LOF) has a central role in the pathogenesis of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). TARDBP mutations are postulated to inactivate TDP-43 functions, leading to impaired RNA proc-essing. However, it has not been fully examined how mutant TDP-43 affects global RNA regulation, especially in human cell models. Here, we examined global RNA processing in forebrain cortical neurons derived from human induced pluripotent stem cells (iPSCs) with a pathogenic TARDBP mutation encoding the TDP-43K263E protein. In neurons expressing mutant TDP-43, we detected disrupted RNA regulation, including global changes in gene ex-pression, missplicing, and aberrant polyadenylation, all of which were highly similar to those induced by TDP-43 knock-down. This mutation-induced TDP-43 LOF was not because of the cytoplasmic mislocalization of TDP-43. Intriguingly, in nonneuronal cells, including iPSCs and neural progenitor cells (NPCs), we did not observe impairments in RNA processing, thus indicating that the K263E mutation results in neuron-specific LOF of TDP-43. This study characterizes global RNA processing impairments induced by mutant TDP-43 and reveals the unprece-dented cell type specificity of TDP-43 LOF in ALS/FTLD pathogenesis.
AB - Transactivating response element DNA-binding protein of 43 kDa (TDP-43), which is encoded by the TARDBP gene, is an RNA-binding protein with fundamental RNA processing activities, and its loss-of-function (LOF) has a central role in the pathogenesis of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). TARDBP mutations are postulated to inactivate TDP-43 functions, leading to impaired RNA proc-essing. However, it has not been fully examined how mutant TDP-43 affects global RNA regulation, especially in human cell models. Here, we examined global RNA processing in forebrain cortical neurons derived from human induced pluripotent stem cells (iPSCs) with a pathogenic TARDBP mutation encoding the TDP-43K263E protein. In neurons expressing mutant TDP-43, we detected disrupted RNA regulation, including global changes in gene ex-pression, missplicing, and aberrant polyadenylation, all of which were highly similar to those induced by TDP-43 knock-down. This mutation-induced TDP-43 LOF was not because of the cytoplasmic mislocalization of TDP-43. Intriguingly, in nonneuronal cells, including iPSCs and neural progenitor cells (NPCs), we did not observe impairments in RNA processing, thus indicating that the K263E mutation results in neuron-specific LOF of TDP-43. This study characterizes global RNA processing impairments induced by mutant TDP-43 and reveals the unprece-dented cell type specificity of TDP-43 LOF in ALS/FTLD pathogenesis.
KW - TDP-43
KW - amyotrophic lateral sclerosis
KW - frontotemporal lobar degeneration
KW - induced pluripotent stem cell
UR - http://www.scopus.com/inward/record.url?scp=85131568360&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131568360&partnerID=8YFLogxK
U2 - 10.1523/ENEURO.0061-22.2022
DO - 10.1523/ENEURO.0061-22.2022
M3 - Article
C2 - 35641224
AN - SCOPUS:85131568360
SN - 2373-2822
VL - 9
JO - eNeuro
JF - eNeuro
IS - 3
M1 - ENEURO.0061-22.2022
ER -